With global recognition of obesity as a complex, chronic disease impacting over one billion people, advancements in obesity clinical development are progressing faster than ever before. Novel pharmacologic agents, advances in lifestyle intervention strategies and new approaches to trial design are reshaping how researchers evaluate efficacy, safety and long‑term outcomes. This fast-paced change brings new opportunities, as well as challenges, to sponsors who are trying to accomplish meaningful and sustainable outcomes.
In this webinar, medical and operational experts discuss key trends and emerging strategies that are shaping the future of obesity research. The discussion covers muscle preservation as a vital endpoint, recognizing that lean mass loss tends to impair one’s physical and metabolic function. This webinar also discusses maintenance therapy and switch designs that address the chronic nature of obesity and the long-term need to maintain the benefits post-initial weight loss.
Watch now to learn the latest trends in obesity clinical development, including methods for incorporating imaging capabilities to capture functional and metabolic health outcomes beyond weight loss.
Global Obesity Capabilities
With decades of phase I-IV metabolic experience and access to in-house and external data streams, Medpace supports the development and execution of rare to large global obesity trials. Medpace has medical, operations, and regulatory staff who understand the complexities of obesity trials from the perspective of the Sponsor, the patients, the clinical investigator, the scientific leader, and the reviewer at the regulatory agencies. Our matured relationships with global thought leaders, investigative sites, the Medpace global ‘flagship’ metabolic site network, and patient advocacy groups, as well as knowledge of effective patient retention strategies, ensure efficient and quality patient enrollment which is key to the success of these programs.